DealTalk: Defenses down, U.S. firms vulnerable to hostile bids

NEW YORK (Reuters) - Takeover defense measures such as poison pills and staggered boards are at their lowest levels in more than a decade, making U.S. companies more vulnerable at a time when hostile bids are expected to rise.